drugset / Trial / NCT05667129
A Phase 1 Study to Evaluate Safety and Tolerability of Single and Multiple Ascending Doses of XEN-101
RandomizedParallel-groupDouble-blindTreatment
Summary
The goal of this study is to assess the safety and tolerability of single and multiple ascending doses of XEN-101
Timeline
- Start
- 2022-12-01
- Primary completion
- 2023-05-30
- Completion
- 2023-05-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | XEN-101 | Unknown | — | — |
Indications
No indication recorded.